BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7299761)

  • 1. C-reactive protein in sera from patients with systemic lupus erythematosus.
    Morrow WJ; Isenberg DA; Parry HF; Snaith ML
    J Rheumatol; 1981; 8(4):599-604. PubMed ID: 7299761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of serum C-reactive protein in systemic lupus erythematosus.
    Williams RC; Harmon ME; Burlingame R; Du Clos TW
    J Rheumatol; 2005 Mar; 32(3):454-61. PubMed ID: 15742436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6.
    Suh CH; Chun HY; Ye YM; Park HS
    Clin Immunol; 2006 Jun; 119(3):291-6. PubMed ID: 16406714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study.
    ter Borg EJ; Horst G; Limburg PC; van Rijswijk MH; Kallenberg CG
    J Rheumatol; 1990 Dec; 17(12):1642-8. PubMed ID: 2084238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-Reactive protein and its implications in systemic lupus erythematosus.
    de Carvalho JF; Hanaoka B; Szyper-Kravitz M; Shoenfeld Y
    Acta Reumatol Port; 2007; 32(4):317-22. PubMed ID: 18159197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein and cognitive deficits in systemic lupus erythematosus.
    Shucard JL; Gaines JJ; Ambrus J; Shucard DW
    Cogn Behav Neurol; 2007 Mar; 20(1):31-7. PubMed ID: 17356342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis.
    Gabay C; Roux-Lombard P; de Moerloose P; Dayer JM; Vischer T; Guerne PA
    J Rheumatol; 1993 May; 20(5):815-21. PubMed ID: 8336307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein in the differential diagnosis between infection and disease reactivation in SLE.
    Bravo MG; Alarcon-Segovia D
    J Rheumatol; 1981; 8(2):291-4. PubMed ID: 7230160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
    Bijl M; Bootsma H; Van Der Geld Y; Limburg PC; Kallenberg CG; Van Rijswijk MH
    Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions.
    Tan Y; Yu F; Yang H; Chen M; Fang Q; Zhao MH
    Hum Immunol; 2008 Dec; 69(12):840-4. PubMed ID: 18852001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Elevated C reactive protein rate in 23 black African patients with systemic lupus erythematosus and without opportunistic infectious disease].
    Iba-Ba J; Biteghe B; Missounga L; Ibouili RB; Mipinda JB; Coniquet S; Kombila JB; Boguikouma JB
    Sante; 2009; 19(2):67-71. PubMed ID: 20031513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis.
    Vogt B; Führnrohr B; Müller R; Sheriff A
    Autoimmunity; 2007 Jun; 40(4):295-8. PubMed ID: 17516213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
    Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
    Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease.
    Bakri Hassan A; Rönnelid J; Gunnarsson I; Karlsson G; Berg L; Lundberg I
    J Autoimmun; 1998 Oct; 11(5):503-8. PubMed ID: 9802936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a relationship between serum C-reactive protein level and dyslipidaemia in systemic lupus erythematosus?
    Albar Z; Wijaya LK
    Acta Med Indones; 2006; 38(1):23-8. PubMed ID: 16479028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erosive arthritis in systemic lupus erythematosus is associated with high serum C-reactive protein and anti-cyclic citrullinated peptide antibodies.
    Amezcua-Guerra LM; Márquez-Velasco R; Bojalil R
    Inflamm Res; 2008 Dec; 57(12):555-7. PubMed ID: 19109734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk in systemic lupus erythematosus--evidence of increased oxidative stress and dyslipidaemia.
    Nuttall SL; Heaton S; Piper MK; Martin U; Gordon C
    Rheumatology (Oxford); 2003 Jun; 42(6):758-62. PubMed ID: 12730535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of the genetic component of basal C-reactive protein expression in SLE nuclear families.
    Rhodes B; Meek J; Whittaker JC; Vyse TJ
    Ann Hum Genet; 2008 Sep; 72(Pt 5):611-20. PubMed ID: 18373721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.